You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 621 A Tregs depleting, CD25-targeted antibody-drug conjugate synergizes with tumor-targeted radiotherapy and systemic interleukin-2 in pre-clinical models of solid cancers

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
621 A Tregs depleting, CD25-targeted antibody-drug conjugate synergizes with tumor-targeted radiotherapy and systemic interleukin-2 in pre-clinical models of solid cancers

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020100022
Dec 202022014
Jan 202124014
Feb 20211803
Mar 202130018
Apr 202120012
May 2021608
Jun 20210010
Jul 2021006
Aug 20210010
Sep 2021006
Oct 202116026
Nov 202128013
Dec 202128010
Jan 20222001
Feb 20223002
Mar 20221603
Apr 20222205
May 20223200
Jun 20221603
Jul 20221803
Aug 20221604
Sep 20221602
Oct 20222603
Nov 20222204
Dec 20222002
Jan 20232003
Feb 20231002
Mar 20232803
Apr 20231605
May 20231801
Jun 20231400
Jul 20232804
Aug 20233404
Sep 20233003
Oct 20233203
Nov 20236203
Dec 20236401
Jan 20242600
Feb 20243002
Mar 20244602
Apr 20243400
May 20243402
Jun 20244001
Jul 20244001
Aug 20242404
Sep 20242202
Oct 20242605
Nov 20241805
Dec 20241406
Jan 20252206
Feb 2025002
Mar 2025004
Apr 2025004
May 2025005
Jun 2025004
Total12780291